Literature DB >> 20555066

Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

H-J Schmoll1, K Jordan, R Huddart, M P Laguna Pes, A Horwich, K Fizazi, V Kataja.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20555066     DOI： 10.1093/annonc/mdq177

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  16 in total

Review 1.  Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.

Authors:  Sukaina Rashid; Louise Lim; Thomas Powles
Journal:  Curr Treat Options Oncol       Date:  2012-06

2.  Erratum to: Dendritic cells as therapeutic targets in neuroinflammation.

Authors:  Felix Luessi; Frauke Zipp; Esther Witsch
Journal:  Cell Mol Life Sci       Date:  2016-07       Impact factor: 9.261

3.  Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patients.

Authors:  Rainer Souchon; Michael Hartmann; Susanne Krege; Anja Lorch; Frank Mayer; Maria De Santis; Silke Gillessen; Jörg Beyer; Richard Cathomas
Journal:  Strahlenther Onkol       Date:  2011-02-21       Impact factor: 3.621

4.  A systematic scoping review of multidisciplinary cancer team and decision-making in the management of men with advanced prostate cancer.

Authors:  A Holmes; B D Kelly; M Perera; R S Eapen; D M Bolton; N Lawrentschuk
Journal:  World J Urol       Date:  2020-06-04       Impact factor: 4.226

5.  [Follow-up of testicular germ cell cancer patients: interdisciplinary evidence-based recommendations].

Authors:  M Hartmann; S Krege; R Souchon; M De Santis; S Gillessen; R Cathomas
Journal:  Urologe A       Date:  2011-07       Impact factor: 0.639

Review 6.  [Follow-up of testicular germ cell tumors-historical aspects and current recommendations].

Authors:  Klaus-Peter Dieckmann; Christian Guido Ruf; Raphael Gübitz; Christian Wülfing; Friedemann Zengerling
Journal:  Urologe A       Date:  2022-04-06       Impact factor: 0.639

7.  Diagnostic accuracy of integrated (18)F-FDG PET/CT for restaging patients with malignant germ cell tumours.

Authors:  P Sharma; T K Jain; G K Parida; S Karunanithi; C Patel; A Sharma; S Thulkar; P K Julka; C Bal; R Kumar
Journal:  Br J Radiol       Date:  2014-06-04       Impact factor: 3.039

8.  18F-FDG PET/CT impact on testicular tumours clinical management.

Authors:  Valentina Ambrosini; Giorgia Zucchini; Silvia Nicolini; Annalisa Berselli; Cristina Nanni; Vincenzo Allegri; Andrea Martoni; Domenico Rubello; Rubello Domenico; Antonia Cricca; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-22       Impact factor: 9.236

Review 9.  Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors.

Authors:  Silvia Schmidtova; Katarina Kalavska; Lucia Kucerova
Journal:  Curr Oncol Rep       Date:  2018-09-26       Impact factor: 5.075

10.  Two cases of cerebral sinus venous thrombosis following chemotherapy for non-seminomatous germ cell tumor.

Authors:  C Papet; A Gutzeit; M Pless
Journal:  Case Rep Oncol       Date:  2011-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.